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The pore structure of Clostridium perfringens
epsilon toxin
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Richard W. Titball6 & Monika Bokori-Brown 6
Epsilon toxin (Etx), a potent pore forming toxin (PFT) produced by Clostridium perfringens, is
responsible for the pathogenesis of enterotoxaemia of ruminants and has been suggested to
play a role in multiple sclerosis in humans. Etx is a member of the aerolysin family of β-PFTs
(aβ-PFTs). While the Etx soluble monomer structure was solved in 2004, Etx pore structure
has remained elusive due to the difficulty of isolating the pore complex. Here we show the
cryo-electron microscopy structure of Etx pore assembled on the membrane of susceptible
cells. The pore structure explains important mutant phenotypes and suggests that the double
β-barrel, a common feature of the aβ-PFTs, may be an important structural element in
driving efficient pore formation. These insights provide the framework for the development
of novel therapeutics to prevent human and animal infections, and are relevant for
nano-biotechnology applications.
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Epsilon toxin (Etx) is a pore-forming toxin (PFT) producedby Clostridium perfringens type B and D strains and playsan important role in the pathogenesis of enterotoxaemia, a
severe neurological disease of domestic ruminants, particularly
sheep. More recently, Etx has been implicated in the development
of multiple sclerosis (MS) in humans1–3.
Etx is typically secreted by the bacterium in the gut as a rela-
tively inactive, water-soluble monomer, called protoxin (P-Etx),
with an estimated molecular weight of 32.9 kDa4. The protoxin is
converted to the active, mature toxin after carboxy- and amino-
termini peptides are removed by proteolytic cleavage in the gut,
either by digestive proteases of the host, such as trypsin, or
protease produced by C. perfringens5. Toxin activation generates a
more acidic protein (isoelectric point of 5.4 vs. 8.3) that is nearly
1000 times more toxic than its progenitor6,7. By a mechanism
unknown, Etx crosses the gut wall, enters the blood stream and
accumulates preferentially in the brain and kidneys8,9.
Etx is a member of the aerolysin family of β-PFTs (aβ-PFTs).
Members of the aβ-PFTs are found in all kingdoms of life and can
be used for either attack or defence10,11. Other bacterial toxins
from the aβ-PFTs that play a role in disease include aerolysin
from the human pathogen Aeromonas hydrophila12, enterotoxin
(CPE) from C. perfringens13, α-toxin from Clostridium septicum14
and monalysin from Pseudomonas entomophila15. Other mem-
bers of the aβ-PFTs serve in defence, such as lysenin produced by
immune cells of the earthworm Eisenia fetida16, assist in prey
digestion, such as hydralysins from Cnidaria17, or have cytocidal
activity against human cancer cells, such as parasporin-2 from
Bacillus thuringiensis18.
As evidenced by their crystal structures, members of the
aβ-PFTs share an overall similar domain arrangement11. They
typically contain one or more receptor-binding domains (RBDs)
and a pore-forming module (PFM), a well-conserved structural
element of the aβ-PFTs11,19. The PFM, rich in serine and
threonine residues, contains a flexible membrane insertion loop
flanked by pre-insertion strands that refold into an amphipathic
β-hairpin during pore formation to create the transmembrane
β-barrel of the pore20.
The crystal structure of the water-soluble, monomeric P-Etx
was solved by Cole et al. in 200421 and revealed an elongated
molecule composed mainly of β-sheets, with two strands traver-
sing the entire molecule. The suggested RBD at the amino ter-
minus contains a cluster of surface-exposed aromatic amino acids
critical for cell binding22,23, and the PFM at the carboxy terminus
is suggested to play a role in oligomerization and pore
formation11,19. The PFM also contains a C-terminal peptide
(CTP), proteolytic removal of which is essential for toxin acti-
vation6 as interaction of the CTP with the pre-insertion strands
restricts their movement, thus preventing pore formation20.
A glycan (β-octyl-glucoside (β-OG)) binding site has also recently
been identified in the PFM, suggesting that Etx may have two
distinct receptor-binding sites22.
Etx is unique amongst aβ-PFTs as it shows high potency and
high cell specificity. The 50% lethal dose (LD50) in mice after
intravenous administration of the toxin is reported to be 100 ng
kg−1 24, which is equivalent to 7 μg per 70 kg human. This makes
Etx the third most potent clostridial toxin after botulinum and
tetanus neurotoxins24. For this reason, Etx is classified as a
potential biological weapon in some countries and as a category B
biological agent by the Centres for Disease Control and Preven-
tion (CDC), the leading public health institute of the United
States25. Among the many cell lines tested, only a few are sus-
ceptible to Etx. Most in vitro studies on Etx, including this study,
have been performed using the Madin–Darby Canine Kidney
(MDCK) cell line as this cell line is the most sensitive to the
toxin26–29. The cell specificity of Etx suggests that the toxin binds
to a specific receptor in the membrane of target cells and this is
likely to explain why the toxin is over 1000 times more potent
compared to other aβ-PFTs.
To date, two putative Etx receptors have been identified: the
O-linked glycoprotein hepatitis A virus cellular receptor 1
(HAVCR1)23 and the tetraspan membrane proteolipid myelin
and lymphocyte protein (MAL)2. The molecular basis for the
interaction of these putative receptors with Etx remains
unknown, although it is thought that the binding site for Etx on
the glycoprotein HAVCR1 includes one of the sugar components,
while in MAL the second extracellular loop is critical for binding
and cytotoxicity of Etx. Etx can also interact with artificial lipid
bilayers and form functional pores without the help of receptors,
albeit with less efficiency30–32.
Both inactive P-Etx and activated toxin can bind to cells,
but only activated toxin with CTP removed can form heptameric
pre-pores on the membrane surface in the next step of pore
formation33. Finally, the heptamer, with a molecular mass of
approximately 155–174 kDa2,28,29,34, inserts into the membrane,
which is triggered by significant structural rearrangements within
the PFM of each protomer in the complex. Pore formation dis-
rupts the membrane and is central to the damage caused to
intoxicated cells, and consequently to the symptoms of disease,
due to the leakage of water and small ions through the pores that
may lead to cell death.
Whilst atomic resolution structures of the water-soluble,
monomeric forms have been determined for many members of
the aβ-PFTs over the past few decades, their corresponding pore
structures have only recently been revealed. The lysenin pore was
the first high-resolution structure of the aβ-PFTs20,35. A 3.9 Å
structure of the aerolysin pre-pore and a 7.5 Å structure of
aerolysin pore have also been determined36.
The cryo-electron microscopy (cryo-EM) structure of Etx pore
determined here provides further insights into the molecular
details of structural rearrangements during pore formation of the
aβ-PFTs. These results will have important implications for the
development of novel therapeutics aimed at the functional dis-
ruption of pore formation to prevent human and animal diseases,
and are relevant for nano-biotechnology applications.
Results
Isolation of the Etx pore. The formation of biologically active
oligomers has been a limiting factor for obtaining structural
information of the pore form of Etx. Unlike aerolysin37,38, Etx
does not spontaneously oligomerize into sodium dodecyl sulfate
(SDS)-resistant species when activated in aqueous buffer, and
negatively stained EM samples do not reveal regular particles
other than elongated monomers and small clumps (Supplemen-
tary Fig. 1a). Furthermore, efficient oligomerization cannot be
promoted by the addition of liposomes of various lipid compo-
sitions or detergent micelles. The uncertainty in receptor identity
combined with the high cell specificity of Etx prompted us to
investigate if the pores could be assembled on susceptible cells
and then purified for structural studies. We assembled Etx oli-
gomers that were biologically active towards Super Dome cells, a
clone of MDCK cells that forms domes that are approximately
five times the area of MDCK cells, thus exhibiting exceptional
sensitivity to Etx39. The cytotoxic activity of trypsin-activated
recombinant wild-type Etx towards Super Dome cells was mea-
sured using a lactate dehydrogenase (LDH) assay. The average
dose of recombinant Etx required to kill 50% of Super Dome cells
(CT50) was 2.47 ± 0.47 nM (SEM) or 78.27 ± 14.89 ngml−1
(SEM) (Fig. 1a). Etx monomers oligomerized and formed SDS-
resistant pores of an apparent molecular weight of ∼155 kDa
on the membrane of Super Dome cells (Fig. 1b), consistent
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with previous studies2,28,29,34. Subsequently, the complexes
were solubilized in detergent and treated as single particles for
cryo-EM analysis. Solubility screening using ultracentrifugation
identified n-dodecyl-β-D-maltoside (DDM) as a suitable deter-
gent, which has previously been successfully used to solubilize
lysenin and Etx pores20,34,35 (Supplementary Fig. 2).
Structural determination of the Etx pore. When observed using
transmission EM, the isolated Etx material appeared hetero-
geneous. The extremely low yields (∼10 µg from 6 × 108 cells)
meant that we could not pursue additional clean-up steps, such as
size-exclusion chromatography. This heterogeneity hindered
particle identification and selection using manual or automated
picking procedures (Supplementary Figs. 3, 4). Despite this, an
initial dataset of 613 micrographs resulted in ∼14,000 particles
after 2D and 3D classification clean-up steps and produced a map
that reached 4.6 Å, at which resolution the β-strands just begin to
separate (Supplementary Fig. 3, inset). We reasoned that the use
of a Volta phase plate (VPP) would be advantageous for two
reasons. First, the contrast of the protein component would
increase, aiding particle picking and alignment. Second, the
number of particles required to achieve a high-resolution struc-
ture could decrease as compared to conventional defocused
data40. Therefore, we proceeded to image the exact same grid
used before with the VPP. Although the samples still appeared
heterogeneous (Fig. 2a), approximately two times as many par-
ticles remained after clean-up steps as compared to the non-VPP
dataset from a dataset that was only 25% larger. This resulted in a
final map at an overall resolution of 3.2 Å (Fig. 2c, d and
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Fig. 1 Cytotoxic activity of wild-type epsilon toxin (Etx) towards Super Dome cells. a The cytotoxic activity of trypsin-activated recombinant wild-type Etx
towards Super Dome cells was determined by measuring the release of lactate dehydrogenase (LDH) from lysed cells. Results were normalized to the
signal from cells treated with Dulbecco’s phosphate-buffered saline (DPBS) only (0% lysis) and cells treated with 0.9% (v/v) Triton X-100 (100% lysis).
Results are presented as the mean of triplicate assays, each performed in triplicate (±SEM). b Purified Etx pore was separated by sodium dodecyl sulfate-
polyacrylamide gel electrophoresis (SDS-PAGE) and visualized by Coomassie staining. Arrows indicate the positions of Etx pore (p) and Etx monomer (m).
Source data are provided as a Source Data file
a b c
d
Fig. 2 Cryo-electron microscopy (EM) of epsilon toxin (Etx) pores using the Volta phase plate. a Electron micrograph of a typical field of view of isolated
Etx pores. Particles that were included in the final 3D map are highlighted. b Characteristic 2D class averages. Sharpened cryo-EM map of the pore
coloured by monomer as visualized from the side (c) and extracellular (d) views. Scale bar corresponds to 50 nm
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Supplementary Fig. 5). Estimation of the B-factors for both
datasets indicated that the phase plate data was indeed of higher
quality when comparing the same number of particles used in a
reconstruction (Supplementary Fig. 6).
Architecture of the Etx pore. The atomic model of the Etx pore
is shown in Fig. 3a, b. The overall architecture of the Etx pore
resembles that of its structural homologues lysenin20,35 and
aerolysin36, with a β-barrel that spans the height of the molecule,
a motif that so far seems specific for the aβ-PFTs. The Etx pore
also lacks a vestibule that is found in the α-hemolysin family of β-
PFTs where the β-barrel begins close to the membrane-spanning
region (Supplementary Fig. 7a, d, respectively). The Etx assembly
measures ~120 Å across and ~98 Å in height. The lumen of the β-
barrel measures ~24 Å (Cα–Cα) at its widest, although local
restrictions are present (see below).
Each protomer in the pore structure can be divided into three
domains (Fig. 3a, b): the β-hairpin domain (blue), the cap domain
(yellow) and the RBD (green). The β-hairpin domain (residues
95–173) creates the inner β-barrel, which begins at the top of the
pore and runs through the entire length of the assembly,
including the membrane-spanning region. The cap domain
(residues 63–94, 174–198 and 235–260) at the extracellular side,
also referred to as the collar35, includes an outer β-barrel that
surrounds the membrane-distal region of the inner β-barrel, and
thus contributes to the highly conserved, concentric double
β-barrel (DBB) fold, a common feature of the aβ-PFTs41. The
RBD (residues 1–62 and 199–234) is unique to each aβ-PFT and
determines the binding specificity of the toxin.
The β-hairpin domain. As has been shown previously20, mem-
bers of the aβ-PFTs form β-barrels that span the height of their
pores. This domain includes the insertion loops that have been
hypothesized to form the membrane-spanning regions (Etx
residues 123–148)21,42,43. As in lysenin, in fact the β-barrel
recruits polypeptide from the flanking β-strands on either side of
the insertion loop so that the β-hairpin domain actually com-
prises residues 95–173. The lumen of the pore is mostly lined
with serine and threonine residues, yet another characteristic of
the aerolysin family, but asparagine and glutamine residues are
also present. Additionally, a number of salt bridges are present
(Supplementary Fig. 8c–e). Forming intra-chain bridges are
Lys99-Asp168 and Lys108-Glu159. Lys130 with Glu137 form an
inter-chain salt bridge, which stabilizes the β-barrel near the
intracellular side of the pore in addition to the hydrogen bonding
network. The overall charge distribution in the lumen is therefore
neutral (Supplementary Fig. 9b). At its narrowest point the dia-
meter of the lumen is constricted to ~12 Å by the seven Lys108
residues, which protrude into the lumen (Supplementary Figs. 8a,
9b, rectangle). The structure corroborates studies that show Etx
has only a slight preference for anions31,32. The β-turn at the
intracellular side is formed by Thr132, Val133, Pro134 and
Phe135. Aerolysin and Etx are conserved in this region. Pro134 is
equivalent to Pro248 in aerolysin and, as in aerolysin, the β-turn
main chain protrudes sideways, forming a rivet to anchor the
barrel at the intracellular side (Fig. 3c)44.
The external surface of the Etx inner β-barrel reveals a number
of interesting features (Fig. 3c). In the intracellular side of the
membrane two aromatic residues, Phe131 and Phe135, form the
usual aromatic belt found in β-barrel transmembrane regions.
However, in the extracellular side of the membrane there are two
aromatic belts. One is formed by Tyr146 ~30 Å from the tip, and
the other formed by His119 (H106 in Etx without propeptide45)
and Phe148 ~35 Å from the tip.
Examination of the unfiltered maps indicates that the detergent
micelle density extends above His119 and Phe148, suggesting that
these residues will be interacting with the membrane (Supplementary
Fig. 10). Therefore, we propose that the membrane-inserted region in
the Etx pore comprises residues 119–148, close to the original
prediction21. Interestingly, histidine residues were also found in the
detergent micelle region of lysenin above the standard aromatic belt20.
Towards the membrane-distal part of the inner β-barrel, His162
N
C
98 Å
H119
Y146
F148
F131F135
Y42 Y43
Y209
Y49
D250
~35 Å
~30 Å H162
Y84
F105
a
c 120 Å
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d
Fig. 3 Atomic model of the epsilon toxin (Etx) pore. Cartoon representation of the heptameric Etx model with height, width and lumen dimensions
indicated (a, b). The monomers are coloured by domain: green—receptor-binding domain (RBD); blue—β-hairpin domain; yellow—cap domain. c Close-up
view of the inner β-barrel and membrane-spanning region. Residues identified in previous studies as important to receptor binding in the RBD, as well as
residues forming the aromatic belts, are highlighted in stick representation. The approximate boundaries of the lipid bilayer are coloured light brown.
d Close-up view of the double β-barrel (DBB) fold viewed from the membrane side with interacting residues shown in stick representation
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(H149 in Etx without propeptide) is another important residue for
Etx activity22,45. H162 (Nδ1) is within hydrogen bonding distance of
D250 (Oδ2), which lies in the cap domain of the same chain (Fig. 3d
and Supplementary Fig. 8a).
The RBD. This region undergoes minimal conformational
changes in the transition from the water-soluble form, as in
lysenin20. Unique to Etx, and unlike lysenin and aerolysin, the
individual RBDs are well separated and do not interact with their
neighbours (Fig. 3b and Supplementary Fig. 7a–c), and thus do
not contribute to any oligomerization surfaces. The lack of phy-
sical constraints in the RBD could infer higher flexibility in
receptor selection and binding, and in part explains why the
resolution of this domain is lower than that of the other domains
(Supplementary Fig. 5). Overall, the RBD in the oligomer overlaps
well with the corresponding region of the crystal structure of Etx
in its monomeric form (PDB ID: 1UYJ) (Supplementary Fig. 11),
with a root-mean-square deviation of 1.7 Å (Cα–Cα). A number
of tyrosine residues (Tyr 42, 43, 49 and 209; corresponding to Tyr
29, 30, 36 and 196 in refs. 22,46), which were identified in earlier
studies as important in receptor binding22,46, are located directly
above the membrane in a position that would facilitate interaction
with a receptor (Fig. 3c). As shown in Supplementary Fig. 9a, d,
the tips of the RBD are predominantly hydrophobic.
The cap domain. The cap domain links the RBD to the β-hairpin
domain and undergoes significant rearrangement in the pore
form, as discussed below. In the pore conformation it contributes
the outer β-barrel to the DBB fold (Fig. 3d). In aerolysin, the DBB
fold has been shown to be responsible for the SDS-resistant
character of aerolysin36. In Etx the DBB fold is stabilized by
hydrophobic interactions between the inner and outer β-barrel
that includes valines, leucines, isoleucines and offset π–π stacking
between Tyr84 and Phe105 residues, as well as some hydrogen
bonds, including H162 and D250 mentioned above (Fig. 3d and
Supplementary Fig. 8a, b).
To investigate the importance of the H162–D250 interaction,
we constructed D250A and H162A mutants. Etx-H162A (corre-
sponding to H149A in ref. 45) has previously been reported to
have reduced, but not abolished, toxicity45, and the crystal
structure of P-Etx-H162A closely resembles that of wild-type
P-Etx22, while purified recombinant Etx-D250A is completely
inactive towards Super Dome cells, as shown in Supplementary
Fig. 12a, and thermal stability assays indicate that P-Etx-D250A
behaves similarly to wild-type P-Etx (Supplementary Fig. 12b),
suggesting that P-Etx-D250A is correctly folded. Examination of
D250 and H162 in the monomeric Etx crystal structure indicates
that D250 and H162 are not involved in any interactions,
suggesting that the importance of these residues lies in the
H162–D250 hydrogen bond formed in the oligomer. SDS-PAGE
analysis of oligomer formation revealed that both Etx-D250A
and Etx-H162A produce SDS-resistant oligomers of the
same apparent molecular weight as wild-type Etx (∼155 kDa,
consistent with previous reports2,28,29,34) (Supplementary Fig. 13,
lanes 11–13). When Super Dome cells were incubated with
activated wild-type Etx, Etx-D250A or Etx-H162A, oligomers
were formed with a mean oligomer yield of 5.09 ± 2.62%
(SEM) for Etx-D250A (Supplementary Fig. 13b), albeit in a
concentration-dependent manner (Supplementary Fig. 14), and
with a mean oligomer yield of 44.54 ± 10.25% (SEM) for Etx-
H162A relative to wild-type Etx (Supplementary Fig. 13b). These
results suggest that while D250A oligomers resembling the wild-
type ones, either in a pre-pore or post-pre-pore state, can
assemble, they cannot produce pores that have a cytotoxic effect
on cells (Supplementary Fig. 12a), even at the highest concentra-
tion of 6 µM tested (2426 times the CT50 dose of wild-type Etx).
Further analysis of oligomer formation by native-PAGE revealed a
much larger complex of ∼624 kDa relative to the SDS-resistant
oligomers of ∼155 kDa when Super Dome cells were incubated
with activated wild-type Etx (Supplementary Fig. 15, lane 10). The
same complex, albeit at lower intensity, was also observed when
cells were incubated with activated Etx-H162A (Supplementary
Fig. 15, lane 12), but was not detectable when cells were incubated
with activated Etx-D250A (Supplementary Fig. 15, lane 11),
providing further evidence that D250A oligomers detected by
SDS-PAGE may not correspond to pores. Both D250A and
H162A mutants retain their ability to bind to Super Dome cells
(Supplementary Fig. 13a, lanes 8–13, and Supplementary Fig. 15a,
lanes 7–12), suggesting that residues D250 and H162 are
important for events downstream of receptor binding. Similar to
activated wild-type Etx, negative stain EM did not reveal regular
particles other than elongated monomers and small clumps for
activated Etx-D250A and Etx-H162A (Supplementary Fig. 1).
Structural rearrangements during pore formation. Comparison
of the crystal structure of Etx monomer to its membrane-inserted
form illustrates the large conformational changes that occur upon
pore formation (Fig. 4 and Supplementary Movie 1). The cap
45 Å
a b c
Fig. 4 Conformational changes accompanying pore formation. Wire representation of epsilon toxin (Etx) monomers in the water-soluble and membrane-
inserted state coloured by domain as in Fig. 3 and viewed from different angles (a–c). The two models were superimposed by their receptor-binding
domain (RBD), which remains mostly unchanged during the transition. The cap domain collapses by 45 Å allowing the pre-insertion strands to get closer to
the membrane and form the inner β-barrel. The heptameric pore is also shown for context. Curved arrow in c illustrates outward movement of the cap
domain in the membrane-inserted form
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domain moves downward towards the membrane by 45 Å
creating a kink in the straight cap domain. In turn, the β-hairpin
domain, consisting of the hypothetical insertion loop and the pre-
insertion strands, as for lysenin20, unfolds to create the inner
β-barrel that spans the entire length of the Etx pore. In contrast to
lysenin, the cap domain in Etx moves slightly away from the
inner β-barrel rather than towards it.
To further understand how Etx assembles into an oligomer and
the rearrangements required for transition to the pore state, we
constructed a hypothetical pre-pore by superimposing the crystal
structure monomer to the RBD of the pore structure and
imposing 7-fold symmetry, similar to hypothetical pre-pores
constructed previously for lysenin20,35. This allowed us to observe
some of the displacements that have to occur prior to pre-pore
formation (Supplementary Fig. 16). Calculations of molecular
clashes (inter-atom overlap >0.6 Å) highlight the potential regions
that would have to rearrange upon oligomerization. It is clear
from these clashes that the CTP, as expected, severely obstructs
oligomerization, and the pre-pore model illustrates why this
region must be removed prior to monomer association. In
addition to the CTP, other significant clashes occur near the
oligomerization surfaces on either side of a monomer, indicating
again that some rearrangement will have to happen. Finally, the
hypothetical insertion loop or tongue also creates clashes upon
monomer association and, as described previously for lysenin35,
the displacement of the tongue region may be the driving force
for the pre-insertion strands to unfold and the formation of the
inner β-barrel.
Discussion
The pore form of Etx has long eluded structural determination,
mostly owing to the difficulty of forming biologically active Etx
oligomers in liposomes of various lipid compositions or detergent
micelles without a receptor, which is unknown. Thus, the only
viable way to study the pore form of Etx was to isolate the
complexes directly from cells known to be susceptible to Etx.
In this study, the use of Super Dome cells, reported to have 3- to
78-fold increased sensitivity to Etx relative to MDCK cells39,
combined with the use of increased concentration of DDM (2%
(w/v)) relative to 0.05% (w/v) used in ref. 34 maximized pore yield
for subsequent purification, and thus were critical for structural
determination of the Etx pore complex. Furthermore, due to the
very small quantities of material that can be isolated from the
membrane of cultured cells and the heterogeneity of the purified
samples, cryo-EM technique was the only structural method that
could be employed. Use of the VPP proved essential in our stu-
dies to achieve high resolution, owing to the challenging sample
rather than its molecular mass (∼225 kDa). First, particles could
be identified by the automatic and manual picking procedures
more efficiently, resulting in more particles (Supplementary
Fig. 4). Second, the overall quality of the data, as judged by B-
factor estimation from both datasets, was higher for the VPP data,
meaning we could achieve higher resolution than with the non-
VPP data, given the number of particles (Supplementary Fig. 6).
While this manuscript was under review, another cryo-EM study
of a relatively large complex (~500 kDa) also benefited by the use
of the VPP47, suggesting that VPP use could be advantageous for
certain specimens that are not size limited. The resulting map at
3.2 Å resolution allowed an unambiguous model to be built for
Etx pore.
A number of interesting mutants of Etx have been studied in
the past whilst trying to understand how Etx transitions from the
water-soluble to the pore form. Mutating H149 (H162 in our
model) to alanine resulted in a significant decrease in activity of
the recombinant toxin both in vitro and in vivo45. However,
substitution with serine at position 162 does not abolish lethal
activity45, suggesting that H162A is less active not because of
removal of the bulky imidazole side chain, but possibly due to the
loss of a hydrogen bond donor at this position. H162, located in
the membrane-distal part of the inner β-barrel, has previously
been equated to aerolysin Y221, and recent studies proposed that,
similar to the aerolysin Y221G mutant, the Etx-H162A mutant
may prevent the β-hairpin domain involved in pore formation
from unfolding19,41. However, unlike the aerolysin Y221G
mutant, the Etx-H162A mutant did not reveal water-soluble,
heptameric pre-pore particles by negative stain EM (Supple-
mentary Fig. 1b).
Examination of the Etx pore structure reveals that H162 may
also play a role in stabilizing the DBB fold by forming a hydrogen
bond with D250 in the cap domain. This interaction will stabilize
the DBB fold further in addition to the hydrophobic interactions
and make it more rigid. In agreement with this hypothesis, sub-
stitution of aspartate with alanine at position 250 results in a
completely inactive Etx that displays ∼95% reduction in SDS-
resistant oligomers relative to wild-type Etx. The reduced oligo-
merization of Etx-D250A and its complete inactivity towards
Super Dome cells could be a result of either oligomer instability
or a reduction in oligomer formation. Since D250 does not par-
ticipate in any inter-chain interactions in the oligomer, we cannot
explain the latter. The abolished cytotoxicity of Etx-D250A sug-
gests that the SDS-resistant oligomers resembling the wild-type
ones may correspond to pre-pores or post pre-pores. This may
explain why Etx-D250A oligomers resembling the wild-type ones
were not observed by native-PAGE immunoblot. Pre-pores or
post-pre-pores are expected to migrate differently to pores on
native-PAGE as they will lack any associated detergents or lipids.
Further evidence for the importance of the DBB stability in
pore formation also comes from previous mutagenesis studies.
Tyrosine 84 in the cap domain and F105 in the inner β-barrel
have previously been identified as important to Etx function48.
Y84A completely abolishes pore formation and is only recover-
able by substitution to another aromatic residue, whilst F105A
has reduced cytotoxic activity towards MDCK cells at low toxin
concentrations48. In the pore structure, these two residues form a
π-π stacking interaction (Fig. 3d and Supplementary Fig. 8b).
Similar to D250A and H162A mutants, Y84A and F105A mutants
also retain their ability to bind to MDCK cells.
Based on previous studies and the pore structure presented
here, we propose that the stability of the DBB fold may be
important in coupling the conformational changes that occur in
the cap domain (the vertical collapse by 45 Å) to the insertion of
the inner β-barrel into the membrane. By stabilizing the top end
of the inner β-barrel as it is being formed by the unfolding of the
β-hairpin domain, the insertion into the membrane will be ana-
logous to a drill, which is forced into the ground by applying force
at the top. Similarly, the RBDs with their hydrophobic tips may
keep the complex anchored to the membrane during membrane
insertion, analogous to the stabilizing feet of the drill, by either an
interaction with the receptor or with the lipid bilayer itself. The
pre-pore structure of aerolysin by cryo-EM36 showed that the
DBB is already formed at this stage and is a pre-requisite to
insertion of the inner β-barrel into the membrane.
Monomeric P-Etx has previously been crystallized bound to
β-OG in the PFM of the carboxy terminus22. In the pore form of
Etx, the β-OG binding site is disrupted and the interacting resi-
dues (V85, F105 and T106, corresponding to V72, F92 and T93
in22) are scattered amongst the inner β-barrel and the cap
domain. Similar to aerolysin49, in order for Etx to cross the thick
layer of glycocalyx covering the apical side of the plasma mem-
brane of gut epithelial cells, Etx may initially bind to surface
oligosaccharides with low affinity, possibly through the β-OG
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binding site at the carboxy terminus, before it binds with high
affinity to its receptor on the membrane surface through the RBD
at the amino terminus. This hypothesis is supported by the
finding that polarized epithelial cells are more sensitive to Etx
from their apical side, which is more abundant in oligosacchar-
ides, than from their basolateral side29,50. Binding of Etx to a
double receptor in the nervous system has also been suggested
previously9.
Insights into the molecular details of structural rearrangements
and monomer–monomer interactions established upon pore
formation can be applied to structure-based drug design where
high-affinity compounds are identified to block pore formation,
thus fighting bacterial infections. Further studies on Etx will have
important implications for developing novel therapeutics aimed
to disrupt pore formation, thus preventing serious human and
animal infections, and are relevant for nano-biotechnology
applications.
Methods
Materials. Chemicals were purchased from Sigma, UK, unless otherwise stated.
The polyclonal antibody against Etx mutant Y30A-Y196A was raised in rabbits as
described in ref. 51. After electrophoretic separation purified Etx pore was detected
by SimplyBlue staining (Invitrogen Ltd, Paisley, UK). Protein concentrations were
determined using the Pierce™ BCA Protein Assay Kit (Fisher Scientific Ltd,
Loughborough, UK). Synthetic oligonucleotides were sourced from Eurofins
Genomics, Germany.
Recombinant protein production and purification. The gene, etxB, encoding
epsilon protoxin (P-Etx) was PCR amplified using synthetic oligonucleotides Etx-
NcoI-F and Etx-XhoI-R (Supplementary Table 1) designed to bear restriction
enzyme sites NcoI and XhoI, respectively, to facilitate directional cloning into the
expression vector pHis-Parallel1 (GenBank: AF097413.1). This fused the amino-
terminal end of P-Etx without the 14 amino-terminal residues (KEISNTVS-
NEMSKK) to the 26 amino acid residue-long peptide (MSYYHHHHHHDY-
DIPTTENLYFQGAM), which contains an amino-terminal polyhistidine (6× His)
affinity tag upstream of a spacer region (DYDIPTT) and the rTEV protease clea-
vage site (ENLYFQG). The fidelity of PCR amplification was verified by automated
DNA sequencing (Eurofins Genomics, Germany). The recombinant plasmid
expressing P-Etx is termed pHis-Parallel1-P-Etx. Amino acid numbering corre-
sponds to P-Etx with the 13 amino acids amino-terminal peptide sequence, unless
otherwise stated.
For expression of P-Etx, recombinant plasmid pHis-Parallel1-P-Etx was
transformed into E. coli Rosetta 2 (DE3) cells (Merck, Darmstadt, Germany) and
expression of P-Etx was induced using the autoinduction system as described
before22 but with modifications. In brief, cells (100 ml) were grown at ACDP/
ACGM (Advisory Committee on Dangerous Pathogens/Advisory Committee on
Genetic Modification) containment level 3 in ZYM-5052-autoinducing medium
supplemented with 50 μg ml−1 carbenicillin and 34 μg ml−1 chloramphenicol and
cultured at 37 °C for 3 h at 300 rpm, then for a further 24 h at 20 °C at 300 rpm.
Cells were harvested by centrifugation at 10,000 × g for 10 min at 4 °C and the
cell pellet was lysed by 10 ml BugBuster™ Protein Extraction Reagent (Merck,
Darmstadt, Germany) containing rlysozyme™ (0.5 µl at 30 KU µl−1) (Merck,
Darmstadt, Germany) and Benzonase® Nuclease (10 µl at 25 U µl−1) (Merck,
Darmstadt, Germany). The cell suspension was incubated on a rotating mixer for
25 min at room temperature and centrifuged at 16,000 × g for 20 min at 4 °C to
separate soluble and insoluble fractions. The supernatant was loaded onto His
GraviTrap columns (GE Healthcare Life Sciences, Little Chalfont, UK) following
the manufacturer’s guidelines. In brief, His-tagged P-Etx was bound to the affinity
column using a buffer composed of 20 mM sodium phosphate, 500 mM NaCl
and 20 mM imidazole, pH 7.4. The column was washed with a buffer composed
of 20 mM sodium phosphate, 500 mM NaCl and 60 mM imidazole, pH 7.4.
Recombinant P-Etx was eluted in a buffer composed of 20 mM sodium phosphate,
500 mM NaCl and 500 mM imidazole, pH 7.4. All purification steps were carried
out at 4 °C. For buffer exchange and sample clean-up, P-Etx-containing eluate was
applied to a PD-10 Desalting Column (GE Healthcare Life Sciences, Little Chalfont,
UK) and eluted in Dulbecco’s phosphate-buffered saline (DPBS), pH 7.0–7.2
(Invitrogen). Protein concentrations were determined by BCA assay.
Activation of P-Etx by trypsin. Purified recombinant P-Etx was activated with
trypsin, TPCK (L-(tosylamido-2-phenyl) ethyl chloromethyl ketone) treated from
bovine pancreas, which removes the CTP sequence. Trypsin was prepared in DPBS
and added to recombinant P-Etx at 1:100 (w/w) ratio and incubated at room
temperature for 1 h. The reaction was stopped by adding trypsin inhibitor (0.66 mg
per 1 mg trypsin) to the digest. Removal of the CTP sequence was assessed by SDS-
PAGE.
Site-directed mutagenesis. Mutation D250A or H162A was introduced into wild-
type recombinant Etx using primer pairs D250A-F and D250A-R or H162A-F and
H162A-R, respectively (Supplementary Table 1) and the QuickChange Lightning
Site-Directed Mutagenesis Kit (Agilent Technologies Inc., Santa Clara, CA, USA)
according to the manufacturer’s instructions. The presence of the intended
mutation was verified by automated DNA sequencing (Eurofins Genomics,
Germany).
Thermostability assay. Thermostability of purified recombinant P-Etx-D250A
was assessed by mixing purified protein (0.25 mgml−1) with 240× SYPRO Orange
protein gel stain. Fluorescence was monitored using a QuantStudio™ 6 Real-Time
PCR System (Applied Biosystems, USA) with a 1% thermal gradient from 25 °C to
99 °C. The fluorescence data obtained was analysed using the Protein Thermal Shift
Software (Applied Biosystems, USA) to calculate the melting temperature (Tm)
using the Boltzmann method.
Cell culture. Super Dome (ATCC® CRL-2286™; American Type Culture Collection
(ATCC), USA) cells, a canine epithelial-like cell line established by cloning from
the MDCK (ATCC® CCL-34™) cell line, were routinely cultured in Dulbecco’s
modified Eagle’s medium/Ham’s F12 medium (DMEM/F12, HEPES; Life Tech-
nologies) with 2.5 mM L-glutamine, 15 mM HEPES, 0.5 mM sodium pyruvate and
1.2 g l−1 sodium bicarbonate supplemented with 0.05 mM nonessential amino
acids and 10% foetal bovine serum Gold (PAA, Pasching, Austria) at 37 °C in a
humidified atmosphere of 95% air/5% CO2. The culture medium was replaced
every 2 to 3 days. Cells were routinely detached by incubation in trypsin/EDTA and
split as appropriate (typically 1:5 dilutions). For dome formation, Super Dome cells
were fed twice a day by a complete medium change.
Cytotoxicity assay. The cytotoxic activity of trypsin-activated Etx toward Super
Dome cells was determined by measuring the amount of LDH released from the
cytosol of lysed cells into the cell culture medium using the CytoTox 96 Non-
radioactive Cytotoxicity Assay Kit (Promega, Southampton, UK) according to the
manufacturer’s protocol. In brief, a 2-fold dilution series of each activated toxin
(ranging from 139 to 0.067 nM) was prepared in DPBS and added to cells seeded
into 96-well plates (3 × 104 cells per well). Following incubation at 37 °C for 3 h, the
cell culture medium (50 µl) was harvested from cell monolayers, transferred to a
fresh 96-well enzymatic assay plate and 50 µl of reconstituted substrate mix was
added to each well. The plate was incubated for 30 min at room temperature,
protected from light. Absorbance was measured at 490 nm using a Tecan Infinite
200 PRO Microplate Reader (Tecan Group Ltd, Switzerland). The absorbance
values for each sample were normalized by subtracting the absorbance value
obtained for the culture medium from untreated cells. The toxin dose required to
kill 50% of the cell monolayer (CT50) was determined by nonlinear regression
analysis, fitting a variable slope log(dose) vs. response curve, constraining F to a
value of 50 (log CT50= log CTF− (1/HillSlope) × log(F/(100− F)).
Etx pore assembly. Super Dome cells were grown to confluency in 30× T175
flasks. Each flask of cells was incubated with 5 ml cell culture medium containing
trypsin-activated Etx (25 µg ml−1; 50× the average minimum dose required to
lyse 100% cells) at 37 °C for 1 h to allow binding and pore formation. Lysed cells
were centrifuged at 1500 × g for 15 min at 4 °C to pellet cellular debris and
unbound Etx was removed by ultracentrifugation at 100,000 × g for 1 h at 4 °C
using a Beckman Type 70Ti rotor. Solubilization of toxin complex from Super
Dome cells was carried out by resuspending the pellet in DPBS (pH 7.0–7.2)
containing 137 mM NaCl and 2% (w/v) n-dodecyl-β-D-maltoside (DDM) and
incubation at 4 °C overnight, a modification of the method described by Shimada
et al.34 where the toxin complex from MDCK cells was solubilized by resus-
pending the pellet in 20 mM sodium phosphate buffer (pH 7.4) containing
0.05% (w/v) DDM and incubation at 25 °C for 1 h. After incubation, insoluble
material was removed by ultracentrifugation at 75,000 × g for 45 min at 10 °C
using a Beckman Type 70Ti rotor. Solubilized Etx oligomers were bound to
Ni-NTA Agarose resin (Qiagen), washed with 2× 20 volumes of DPBS, 0.02%
(w/v) DDM and eluted in three volumes of DPBS, 200 mM imidazole and 0.02%
(w/v) DDM.
Detergent screening. To screen for a suitable detergent that could efficiently
extract and maintain Etx pores soluble, Super Dome cell membrane was incubated
with trypsin-activated Etx for 1 h at 37 °C and membrane incubations were dis-
tributed between nine tubes. After ultracentrifugation at 100,000 × g for 1 h at 4 °C
using a TLA 120.1 rotor, each pellet was resuspended in DPBS containing 137 mM
NaCl and detergent (1% (w/v) DDM, 1% (w/v) DM (n-decyl-β-D-maltopyrano-
side), 0.5% (w/v) C12E8, 1% (w/v) FC-12, 2% (w/v) β-OG, 2% (w/v) C8E4, 1%
(w/v) CYMAL-5, 1% (w/v) LDAO (lauryldimethylamine-N-oxide) or 1% (w/v)
LMNG (lauryl maltose neopentyl glycol)) and incubated overnight at 4 °C with
occasional shaking. After incubation, 10 µl aliquots were removed from each tube
for Western blot analysis (total protein in detergent) and insoluble material was
removed by ultracentrifugation, as before. The supernatants, which contained
solubilized Etx pore, were collected and 10 µl aliquots were removed from each
tube to assess Etx pore solubilization by Western blot analysis using 6×-His Tag
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Monoclonal Antibody (4A12E4) (Invitrogen, Paisley, UK; catalogue number 37-
2900) and IRDye® 800CW Goat (polyclonal) Anti-Mouse IgG (H+ L), Highly
Cross Adsorbed secondary antibody (LI-COR Biosciences, Lincoln, USA; catalogue
number 926-32210) at 1:500 and 1:5000 dilutions, respectively. The solubilization
yields for each detergent were determined by calculating the % of Etx pore in the
supernatant relative to its amount in the total protein sample using Image Studio
ver 5.2 software (LI-COR Biosciences, Lincoln, USA).
Epsilon pore purification. For DDM-extracted samples, solubilized Etx oligomers
were bound to Ni-NTA resin (Qiagen), washed with 20 volumes of DPBS con-
taining 20 mM imidazole and 0.02% (w/v) DDM, transferred to a Bio-Rad gravity-
flow column, washed again with 20 volumes of DPBS containing 20 mM imidazole
and 0.02% (w/v) DDM, and eluted in three volumes of DPBS containing 200 mM
imidazole and 0.02% (w/v) DDM.
Binding and oligomerization. Super Dome cells were grown to confluence in
6-well plates (1.2 × 106 cells per well), and after washing cells three times with
DPBS to remove residual trypsin, each well was incubated with 2 ml pre-
warmed DMEM-F12 medium containing trypsin-activated recombinant Etx
wild-type, Etx-D250A or Etx-H162A (391 ng ml−1, equivalent to 5× CT50 dose
of wild-type Etx) at 37 °C for 1 h to allow binding and/or oligomerization. Cells
were subsequently washed three times with DPBS to remove unbound Etx, lysed
by three cycles of freezing and thawing in 100 µl DPBS supplemented with
Halt™ Protease Inhibitor Cocktail (100×) (Thermo Fisher Scientific, UK) at a
final concentration of 1× and harvested by scraping. The collected cells were
transferred to a microcentrifuge tube and solubilized in DPBS containing 1% (w/v)
DDM by incubation at 4 °C overnight with occasional shaking. After
incubation, insoluble material was removed by centrifugation at 20,000 × g for 30
min at 4 °C and the concentration of solubilized protein was determined by
BCA assay.
Toxin complexes or monomers in solubilization buffer were analysed by
native-PAGE and SDS-PAGE. Solubilized proteins were resolved by NuPAGE™
7% Tris-Acetate Protein Gels (Invitrogen Ltd., Paisley, UK) using Surelock Xcell
apparatus (Invitrogen Ltd, Paisley, UK). For protein gel electrophoresis under
denaturing running conditions NuPAGE™ Tris-Acetate SDS Running Buffer
(Invitrogen Ltd, Paisley, UK) and NuPAGE LDS sample buffer (Invitrogen Ltd.,
Paisley, UK) were used. For protein gel electrophoresis under native running
conditions Novex™ Tris-Glycine Native Running Buffer (Invitrogen Ltd., Paisley,
UK) and Novex™ Tris-Glycine Native Sample Buffer (Invitrogen Ltd., Paisley,
UK) were used. Denaturing gels were electrophoresed at 150 V for 1 h at room
temperature, while native gels were electrophoresed at 150 V for 2 h in ice cold
running buffer. For SDS-PAGE the molecular weight standard Perfect Protein™
Marker, 10–225 kDa (Merck, Darmstadt, Germany) was used. For native-PAGE,
the molecular weight marker NativeMark™ Unstained Protein Standard
(Invitrogen Ltd., Paisley, UK) was used.
After electrophoresis, proteins in the gel were transferred to a nitrocellulose
membrane using the Trans-Blot® Turbo™ Transfer System (Bio-Rad). The
membrane was blocked with PBS containing 0.1% Tween-20 and 5% skim milk
and bound P-Etx and/or oligomeric complexes were detected with rabbit anti-Etx
polyclonal primary antibody51 at 1:500 dilution and IRDye® 800CW goat anti-
rabbit IgG (H+ L) secondary antibody (LI-COR Biosciences, Lincoln, USA;
catalogue number 926-32211) at 1:5000 dilution. For loading control, the mouse
monoclonal Na+/K+-ATPase α1 (C464.6): sc-21712 primary antibody (Santa Cruz
Biotechnology; catalogue number sc-21712) and the IRDye® 680RD goat
(polyclonal) anti-mouse IgG (H+ L) secondary antibody (LI-COR Biosciences,
Lincoln, USA; catalogue number 925-68070) were used at 1:200 and 1:5000
dilutions, respectively. Antibodies were diluted in PBS containing 0.1% Tween-20
and 3% skim milk. Immuno-reactive bands were detected using the Odyssey CLx
infrared imaging system (LI-COR Biosciences, Lincoln, USA). Quantitative
analyses were performed using the Image Studio ver 5.2 software and the
Housekeeping Protein Normalization Protocol (LI-COR Biosciences, Lincoln,
USA). The oligomer yield for each Etx variant was determined by calculating the
percentage of fluorescence intensity relative to wild-type toxin.
Negative stain EM. Purified recombinant P-Etx variants were trypsin activated as
described above. After activation, samples were diluted to 0.02 mgml−1 and 3 μl
was added to freshly glow-discharged carbon-coated grids for 60 s before staining
with 20 μl of 2% (w/v) aqueous uranyl acetate. Grids were then imaged on a Philips
CM200 FEG transmission electron microscope operating at an accelerating voltage
of 200 kV. Images were recorded at a calibrated pixel size of 2 Å on a TVIPS
F224HD CCD camera.
Specimen preparation and data collection. Etx eluate fraction 4 (∼0.04 mgml−1)
was diluted 3-fold in elution buffer (DPBS containing 20 mM imidazole and 0.02%
(w/v) DDM) and deposited on Quantifoil R1.2/1.3 grids overlaid with graphene
oxide, as described in ref. 20. Grids were then blotted and plunge frozen using a
custom-made device and stored in LN2 until further use. Data were collected on an
FEI Titan Krios operating at an accelerating voltage of 300 kV. All datasets were
collected on an FEI Falcon 3EC direct electron detector at a nominal magnification
of ×75K (calibrated pixel size of 1.07 Å) and a dose rate of 0.6e− per pixel
per second in counting mode over 60 s and 75 fractions. Conventionally defocused
and phase plate datasets were collected using the EPU software (Thermo Fisher
Scientific). In brief, grid squares and suitable holes were selected and microscope
alignments were performed. Just prior to data collection, the phase plate was
inserted and the un-scattered beam was made parallel by observing the Ronchi-
gram in the back focal plane of the objective lens over an empty specimen area.
Condenser astigmatism was corrected by reducing the smearing of the Ronchigram
near the blow-up point. Due to the extremely low screen current used (~0.014 nA),
the 150 μm C2 aperture was used to aid in this process and then switched back to
the 50 μm aperture. Coma and astigmatism were corrected using AutoCTF.
Defocused data were collected by defocusing between −2 and −3.5 μm every 15
μm, and phase plate data between −0.3 and −0.8 μm with focusing at every hole.
Image processing. All datasets were processed in Relion-352. Micrographs were
first corrected for large movements using MotionCorr253 and a 4 × 4 patch with no
grouping. CTF parameters were estimated using GTCF54. Autopicking was per-
formed in Relion after creating references from manually picked particles. The
processing procedure is summarized in Supplementary Fig. 4. The resolution was
calculated using Gold-Standard 0.143 criterion, resulting in a 4.6 Å map for the
defocused dataset and 3.2 Å for the phase plate dataset. The variation in resolution
in the map was calculated using the Relion local resolution implementation. Box
sizes of 220 pixels were used for both the defocused and phase plate datasets. To
ensure that high-resolution information was not lost by the high defocus values
used for the former dataset, particles were re-extracted in 400 pixel boxes and
subjected to 3D refinement. No increase in resolution was observed for the larger
box size particles. B-factor plots were calculated using the bfactor_plot.py scripts
provided with Relion.
Model building and refinement. A model was built into the 3.2 Å map by initially
docking the RBD of wild-type Etx crystal structure (PDB: 1UYJ) and then
extending this using Coot. Refinement of the atomic coordinates was performed
using Phenix55 real space refine and re-iterating the model building-refinement
procedure several times.
Statistics. Data were analysed using the Prism v7 software (GraphPad Software
Inc., La Jolla, CA, USA). Data are expressed as the mean value ± SEM.
Reporting summary. Further information on research design is available in
the Nature Research Reporting Summary linked to this article.
Data availability
Data supporting the findings of this manuscript are available from the corresponding
author upon reasonable request. A reporting summary for this Article is available as
a Supplementary Information file.
The cryo-EM maps of Etx pore have been deposited to the Electron Microscopy Data
Bank under accession number EMD-4789 and the refined atomic coordinates have been
deposited to the Protein Data Bank under accession number 6RB9. The source data for
Fig. 1 and Supplementary Figs. 2, 12–15 are provided as a Source Data file.
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